This topic contains a solution. Click here to go to the answer

Author Question: Females stay longer in detention and have longer stays in juvenile institutions than males for ... (Read 109 times)

ap345

  • Hero Member
  • *****
  • Posts: 537
Females stay longer in detention and have longer stays in juvenile institutions than males for similar offenses.
 
  Indicate whether the statement is true or false

Question 2

There is a lot of controversy over when a youth should be released from training school and who makes that determination. What might be a legitimate reason why a juvenile would be released earlier than preferred by caseworkers?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

robbielu01

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

TRUE

Answer to Question 2

Overcrowding would be a legitimate reason a youth might be released earlier than recommended by caseworkers.




ap345

  • Member
  • Posts: 537
Reply 2 on: Aug 17, 2018
Great answer, keep it coming :)


xiaomengxian

  • Member
  • Posts: 311
Reply 3 on: Yesterday
Excellent

 

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library